NewAmsterdam Pharma Company N.V. (NAMS) Total Assets by Year
NewAmsterdam Pharma Company N.V. closed fiscal year 2025 with $769.3M in total assets, $85.9M in total liabilities and $683.4M in shareholder equity. This represents a decrease of 11.0% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters NewAmsterdam Pharma Company N.V. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NAMS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
NAMS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $704.5M-13.6% | $732.6M-10.5% | $769.3M-11.0% | $786.4M+79.1% | $815.1M+82.5% | $818.4M+67.5% | $864.6M+149.1% | $439.2M | $446.7M | $488.5M | $347.1M-27.5% | N/A |
| Total Liabilities | $73.0M+99.5% | $67.4M+64.2% | $85.9M-19.9% | $58.4M-3.3% | $36.6M-38.2% | $41.0M-46.5% | $107.1M+82.5% | $60.3M | $59.3M | $76.7M | $58.7M+21.2% | N/A |
| Total Equity | $631.4M-18.9% | $665.2M-14.4% | $683.4M-9.8% | $728.1M+92.2% | $778.5M+100.9% | $777.4M+88.8% | $757.5M+162.7% | $378.9M+14.2% | $387.4M+3.8% | $411.8M+3.4% | $288.4M-32.9% | $331.8M |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More NewAmsterdam Pharma Company N.V. financials
Frequently Asked Questions
What was NewAmsterdam Pharma Company N.V.'s total assets in fiscal year 2025?
NewAmsterdam Pharma Company N.V. closed fiscal year 2025 with $769.3M in total assets, $85.9M in total liabilities and $683.4M in shareholder equity.
How fast is NewAmsterdam Pharma Company N.V.'s total assets growing?
NewAmsterdam Pharma Company N.V. (NAMS) total assets fell by 11.0% year over year, from $864.6M to $769.3M in fiscal year 2025.
What was NewAmsterdam Pharma Company N.V.'s total assets in the most recent quarter?
NewAmsterdam Pharma Company N.V. (NAMS) reported $704.5M in total assets in Q2 2026. This represents a decrease of 13.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what NewAmsterdam Pharma Company N.V. (NAMS) reported on that line in every period on record.